Analystreport

Crescent Biopharma (CBIO) had its price target lowered by HC Wainwright from $25.00 to $22.00. They now have a "buy" rating on the stock.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors